CN111979189A - 一种羊膜间充质干细胞分离培养扩增方法 - Google Patents
一种羊膜间充质干细胞分离培养扩增方法 Download PDFInfo
- Publication number
- CN111979189A CN111979189A CN202010863160.4A CN202010863160A CN111979189A CN 111979189 A CN111979189 A CN 111979189A CN 202010863160 A CN202010863160 A CN 202010863160A CN 111979189 A CN111979189 A CN 111979189A
- Authority
- CN
- China
- Prior art keywords
- stem cells
- mesenchymal stem
- culture
- amniotic
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 93
- 238000000034 method Methods 0.000 title claims abstract description 48
- 230000003321 amplification Effects 0.000 title claims abstract description 25
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 25
- 238000004140 cleaning Methods 0.000 claims abstract description 19
- 238000000926 separation method Methods 0.000 claims abstract description 17
- 238000012258 culturing Methods 0.000 claims abstract description 14
- 210000004027 cell Anatomy 0.000 claims description 66
- 210000001691 amnion Anatomy 0.000 claims description 60
- 210000001519 tissue Anatomy 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 41
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 33
- 239000012894 fetal calf serum Substances 0.000 claims description 32
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 22
- 238000011081 inoculation Methods 0.000 claims description 18
- 239000008055 phosphate buffer solution Substances 0.000 claims description 18
- 238000004113 cell culture Methods 0.000 claims description 16
- 210000003954 umbilical cord Anatomy 0.000 claims description 16
- 238000005406 washing Methods 0.000 claims description 16
- 210000005059 placental tissue Anatomy 0.000 claims description 14
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 12
- 210000001136 chorion Anatomy 0.000 claims description 12
- 229930182555 Penicillin Natural products 0.000 claims description 11
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 11
- 229940049954 penicillin Drugs 0.000 claims description 11
- 229960005322 streptomycin Drugs 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 10
- 230000012010 growth Effects 0.000 claims description 10
- 238000013441 quality evaluation Methods 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000004069 differentiation Effects 0.000 claims description 8
- 238000011156 evaluation Methods 0.000 claims description 8
- 238000010008 shearing Methods 0.000 claims description 8
- 210000003754 fetus Anatomy 0.000 claims description 7
- 230000004927 fusion Effects 0.000 claims description 7
- 108010019160 Pancreatin Proteins 0.000 claims description 6
- 208000007536 Thrombosis Diseases 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 239000002777 nucleoside Substances 0.000 claims description 6
- 150000003833 nucleoside derivatives Chemical class 0.000 claims description 6
- 229940055695 pancreatin Drugs 0.000 claims description 6
- 210000002826 placenta Anatomy 0.000 claims description 6
- 241000204031 Mycoplasma Species 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 230000008901 benefit Effects 0.000 claims description 5
- 230000007480 spreading Effects 0.000 claims description 5
- 238000003892 spreading Methods 0.000 claims description 5
- 238000003908 quality control method Methods 0.000 claims description 4
- 238000011160 research Methods 0.000 claims description 4
- 230000009194 climbing Effects 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 230000029087 digestion Effects 0.000 description 17
- 210000000130 stem cell Anatomy 0.000 description 12
- 229960001484 edetic acid Drugs 0.000 description 11
- 230000008569 process Effects 0.000 description 9
- 230000035755 proliferation Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000008827 biological function Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000012136 culture method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 102100022464 5'-nucleotidase Human genes 0.000 description 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
- 102100037241 Endoglin Human genes 0.000 description 2
- 102000006354 HLA-DR Antigens Human genes 0.000 description 2
- 108010058597 HLA-DR Antigens Proteins 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 2
- 102100022338 Integrin alpha-M Human genes 0.000 description 2
- 230000009815 adipogenic differentiation Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000009816 chondrogenic differentiation Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 210000001654 germ layer Anatomy 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000009818 osteogenic differentiation Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical group C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 210000003425 amniotic epithelial cell Anatomy 0.000 description 1
- 210000003663 amniotic stem cell Anatomy 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002219 extraembryonic membrane Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000002660 stem cell treatment Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010863160.4A CN111979189A (zh) | 2020-08-25 | 2020-08-25 | 一种羊膜间充质干细胞分离培养扩增方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010863160.4A CN111979189A (zh) | 2020-08-25 | 2020-08-25 | 一种羊膜间充质干细胞分离培养扩增方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111979189A true CN111979189A (zh) | 2020-11-24 |
Family
ID=73443665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010863160.4A Pending CN111979189A (zh) | 2020-08-25 | 2020-08-25 | 一种羊膜间充质干细胞分离培养扩增方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111979189A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420184A (zh) * | 2015-12-11 | 2016-03-23 | 郭镭 | 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法 |
CN110540959A (zh) * | 2019-10-08 | 2019-12-06 | 孟明耀 | 一种脐带间充质干细胞分离培养扩增方法 |
-
2020
- 2020-08-25 CN CN202010863160.4A patent/CN111979189A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420184A (zh) * | 2015-12-11 | 2016-03-23 | 郭镭 | 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法 |
CN110540959A (zh) * | 2019-10-08 | 2019-12-06 | 孟明耀 | 一种脐带间充质干细胞分离培养扩增方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110540959A (zh) | 一种脐带间充质干细胞分离培养扩增方法 | |
CN106754674B (zh) | 从人胎盘羊膜制备羊膜间充质干细胞的方法及其应用 | |
CN105238751B (zh) | 一种脐带组织间充质干细胞的分离培养方法 | |
CN105765060B (zh) | 羊膜间充质系细胞组合物的制造方法和冷冻保存方法、以及治疗剂 | |
CN109234229B (zh) | 从胎盘血管分离间充质干细胞的方法和所用消化酶组合物 | |
CN108220229B (zh) | 一种提高脐带来源间充质干细胞原代细胞产量的制备方法 | |
CN107164319B (zh) | 一种原代培养犬脐带来源的间充质干细胞的方法 | |
CN113249317A (zh) | 一种人脐带间充质干细胞的分离培养扩增方法及系统 | |
CN104762257B (zh) | 一种从脐带制备间充质干细胞的方法 | |
CN101591644A (zh) | 临床治疗用脐带间充质干细胞的制备和储存 | |
CN108192862A (zh) | 一种鹿茸干细胞的制备方法、鹿茸干细胞及其应用 | |
CN108865988A (zh) | 一种人羊膜间充质干细胞分离、培养及纯化方法 | |
CN104651305A (zh) | 一种利用脐带间充质干细胞获取生物活性蛋白的方法 | |
CN111346051A (zh) | 一种用于治疗脑梗死的脐带间充质干细胞注射液制备方法 | |
CN112029713A (zh) | 一种绒毛膜间充质干细胞分离培养扩增方法 | |
CN107354130B (zh) | 一种人胎盘绒毛膜间充质干细胞分离方法 | |
CN115851587A (zh) | 一种人源胎盘来源间充质干细胞的优化培养基、试剂盒和培养方法 | |
CN104726403A (zh) | 一种人胎盘来源间充质干细胞的分离、培养方法 | |
CN104726401A (zh) | 一种利用胎盘间充质干细胞提高脐血间充质干细胞培养成功率的方法 | |
CN107287158A (zh) | 从小鼠致密骨中高效获取间充质干细胞的方法 | |
CN112522192A (zh) | 牙髓间充质干细胞的分离培养方法 | |
CN114752559B (zh) | 一种人胎盘绒毛膜间充质干细胞的分离培养扩增方法 | |
CN111979188A (zh) | 一种胎盘间充质干细胞分离培养扩增方法 | |
RU2645255C1 (ru) | Способ получения биобезопасной культуры мезенхимальных стволовых клеток из ворсин хориона человека | |
CN104818243A (zh) | 一种胎盘源胎儿干细胞的分离方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240611 Address after: Room 50350, Building D, Phase II, New Drug Creation Base, No.1 Yaocheng Avenue, Medical High tech Industrial Development Zone, Taizhou City, Jiangsu Province, 225316 Applicant after: Jiangsu Saiyi Biotechnology Co.,Ltd. Country or region after: China Address before: Building C2-1, Building 16, Shuwu, No. 73 Tanmi Road, Jiangbei New District, Nanjing City, Jiangsu Province, 211500 Applicant before: Jiangsu Saiyi Cell Technology Research Institute Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right |